PRIMECAP Management Co. Discloses 5.6M Share Stake in Pulmonx Corp.
Ticker: LUNG · Form: SC 13G/A · Filed: Feb 12, 2024 · CIK: 1127537
| Field | Detail |
|---|---|
| Company | Pulmonx Corp (LUNG) |
| Form Type | SC 13G/A |
| Filed Date | Feb 12, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Sentiment | bullish |
Complexity: simple
Sentiment: bullish
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**PRIMECAP just revealed a big stake in Pulmonx, signaling institutional confidence.**
AI Summary
PRIMECAP Management Company, an investment adviser, filed an amended SC 13G/A on February 12, 2024, disclosing its ownership in Pulmonx Corp (NASDAQ: LUNG). As of December 31, 2023, PRIMECAP beneficially owned 5,646,451 shares, representing a significant stake in the medical device company. This filing indicates a notable position by a major institutional investor, which could signal confidence in Pulmonx's future performance.
Why It Matters
This filing shows a major institutional investor, PRIMECAP Management Company, holds a substantial position in Pulmonx, which can be seen as a vote of confidence and may influence other investors.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of institutional ownership and does not inherently present new risks to investors.
Analyst Insight
A smart investor would note this significant institutional ownership as a potential positive signal and research Pulmonx Corp's fundamentals and recent performance to understand PRIMECAP's investment thesis.
Key Numbers
- 5,646,451 — Shares Beneficially Owned (This is the total number of Pulmonx Corp shares PRIMECAP Management Company reported owning as of December 31, 2023.)
- 5,200,851 — Sole Voting Power Shares (This represents the number of shares over which PRIMECAP Management Company has exclusive voting control.)
Key Players & Entities
- PRIMECAP Management Company (company) — the reporting person and institutional investor
- Pulmonx Corp (company) — the subject company whose shares are being reported
- 5,646,451 (dollar_amount) — total shares beneficially owned by PRIMECAP
- December 31, 2023 (date) — the date of the event requiring the filing
- February 12, 2024 (date) — the filing date of the SC 13G/A
Forward-Looking Statements
- PRIMECAP Management Company will maintain a significant stake in Pulmonx Corp. (PRIMECAP Management Company) — medium confidence, target: December 31, 2024
FAQ
What is the purpose of an SC 13G/A filing?
An SC 13G/A is an amendment to a Schedule 13G, which is filed by institutional investors to report beneficial ownership of 5% or more of a company's stock, typically for passive investment purposes. This specific filing (Amendment No. 4) updates previous disclosures by PRIMECAP Management Company regarding its stake in Pulmonx Corp.
Who is the reporting person in this filing?
The reporting person is PRIMECAP Management Company, an investment adviser located at 177 East Colorado Blvd., 11th Floor, Pasadena, CA 91105, as stated in the filing.
What is the subject company of this filing?
The subject company is Pulmonx Corp, with its business address at 700 Chesapeake Drive, Redwood City, CA 94063, as detailed in the filing.
How many shares of Pulmonx Corp did PRIMECAP Management Company beneficially own as of the reporting date?
As of December 31, 2023, PRIMECAP Management Company beneficially owned 5,646,451 shares of Pulmonx Corp, with sole dispositive power over these shares, according to the filing's cover page.
What is the CUSIP number for Pulmonx Corp's securities mentioned in the filing?
The CUSIP number for Pulmonx Corp's class of securities (COM) is 745848101, as indicated on the cover page of the Schedule 13G.
Filing Stats: 993 words · 4 min read · ~3 pages · Grade level 8.5 · Accepted 2024-02-12 16:01:34
Filing Documents
- lunga4_21224.htm (SC 13G/A) — 26KB
- 0001085146-24-001097.txt ( ) — 27KB
(a)
ITEM 1(a). NAME OF ISSUER: Pulmonx Corp
(b)
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 700 Chesapeake Drive, Redwood City, CA 94063
(a)
ITEM 2(a). NAME OF PERSON FILING: PRIMECAP Management Company
(b)
ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 177 E. Colorado Blvd., 11th Floor, Pasadena, CA 91105
(c)
ITEM 2(c). CITIZENSHIP: U.S.A.
(d)
ITEM 2(d). TITLE OF CLASS OF SECURITIES: COM
(e)
ITEM 2(e). CUSIP NUMBER: 745848101 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c); (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) [X] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution: ITEM 4. (a) Amount beneficially owned: 5,646,451 (b) Percent of class: 14.74% (c) Number of shares as to which the person has: (i) sole power to vote or to direct the vote: 5,200,851 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or direct the disposition of: 5,646,451 (iv) shared power to dispose or to direct the disposition of: 0 ITEM 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securiti